Novalix is a premier drug discovery CRO
Novalix stands as a leading biotechnology research organization, dedicated to providing exceptional drug discovery services to both biotech firms and pharmaceutical companies. With a commitment to scientific excellence, Novalix leverages its talent and exclusive resources across multiple platforms to enhance the success rate at each critical pre-clinical stage.
Located at 16, Rue d'Ankara, Strasbourg, Grand Est 67000, FR, Novalix is focused on improving the odds of success in drug discovery. Through advanced technologies, including FBDD, SPR, Medicinal chemistry, and more, Novalix ensures that every project benefits from the highest standards of scientific rigor and innovation.
Novalix is committed to pioneering advancements in biotechnology research. We invite the management team at Novalix to create a customized and exclusive company showcase and product listing on our platform, further highlighting your contributions to the industry.
Novalix est une organisation de recherche biotechnologique de premier plan, dédiée à fournir des services exceptionnels de découverte de médicaments aux entreprises biotechnologiques et pharmaceutiques. Avec un engagement envers l'excellence scientifique, Novalix tire parti de ses talents et de ses ressources exclusives sur plusieurs plateformes afin d'améliorer le taux de réussite à chaque étape préclinique critique.
Situé au 16, Rue d'Ankara, Strasbourg, Grand Est 67000, FR, Novalix se concentre sur l'amélioration des chances de succès dans la découverte de médicaments. Grâce à des technologies de pointe, notamment FBDD, SPR, la chimie médicinale, et plus encore, Novalix veille à ce que chaque projet bénéficie des normes les plus élevées de rigueur et d'innovation scientifiques.
Novalix s'engage à faire progresser la recherche biotechnologique. Nous invitons l'équipe de direction de Novalix à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, soulignant ainsi vos contributions à l'industrie.
Compare Novalix with 3 companies in Biotechnology-Research
| Comparison Field |
NovalixMain Company |
Bruker BioSpinView Profile |
VernalisView Profile |
MagritekView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1960 | 1997 | 2004 |
|
Company Size
|
— | 1,001-5,000 | 51-200 | 51-200 |
|
City
|
Strasbourg, Grand Est | Ettlingen, Baden-Württemberg | Cambridge, Cambs | |
|
Country
|
France | Germany | United Kingdom | |
|
Skills & Keywords
Comparing with main company
|
22 Total Skills
Biotechnology Research
Drug Discovery
FBDD
SPR
Medicinal Chemistry
Pharmaceutical Research
Pre-clinical development
Medicinal chemistry
Chemical process research
Epigenetic targets
cryo-electron microscopy
Flow chemistry
in vitro pharmacology
Native mass spectrometry
Nuclear receptors
Target based drug discovery
Structural Biology
Protein-ligco-crystal structures by XRD
Chemical development
DNA-encoded libraries
NMR
Organic Chemistry
|
18 Total
18 Unique
Unique Skills:
Biotechnology
Clinical research
CT
Drug discovery
EPR
Food analysis
+12
|
18 Total
18 Unique
Unique Skills:
assay technology
biophysics
Cell biology
cheminformatics
CNS
DMPK
+12
|
10 Total
10 Unique
Unique Skills:
Chemistry
Electrolytes
Forensics
Magnetic Resonance
Molecular weight
MRI
+4
|
Other organizations in the same industry
This company is also known as